Celera Corporation is a healthcare enterprise founded in 1998, specializing in the creation of personalized solutions for disease management. Their slogan, "Harnessing the power of human variability to create personalized diagnostic solutions for better disease management," encapsulates their mission. The company's focus lies in leveraging their understanding of human variability to offer innovative tests and services aimed at personalizing disease management. Celera's product division is dedicated to developing and manufacturing molecular diagnostic products utilized by hospitals and clinical laboratories for detecting, characterizing, monitoring, and selecting treatments for various diseases. Notably, the company has a distribution agreement with Abbott, facilitating the development and commercialization of a diverse range of molecular diagnostic products, with Abbott serving as the distribution partner. Operating within the Health Care sector, Celera Corporation presents an intriguing investment opportunity within the ever-evolving landscape of personalized diagnostic solutions.
There is no investment information
No recent news or press coverage available for Celera Corporation.